North America mycotoxin testing market is projected to register a substantial CAGR of 6.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
North America Mycotoxin Testing Market, By Type (Aflatoxins, Ochratoxins, Fusarium Toxins, Deoxynivalenol, Patulin, Penicillium Toxins, Cyclopiazonic Acid, Ergot Alkaloids, Citrinin, Sterigmatocystin, Alternaria, T-2 Toxin, Zearalenone, Others), Product Type (Devices, Reagents & Kits, Services), Technology (Chromatography Based, Immunoassay-Based, Lateral Flow Assay Based, Spectroscopy Based, Others), Sample (Food, Feed, Pharmaceuticals), End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries, Other), Country (U.S., Canada, Mexico) – Industry Trends & Forecast to 2027
Some of the major factors contributing to the growth of the North America mycotoxin testing market are:
• Raising mycotoxins production owing to humid atmospheric conditions.
• Increasing need for food safety.
Market Players:
The key market players for North America mycotoxin testing market are listed below:
• Bureaus Veritas
• Intertek Group plc
• Eurofins Scientific
• NEOGEN Corporation.
• LGC Limited (A SUBSIDIARY OF KOHLBERG KRAVIS ROBERTS & CO. L.P.)
• EnviroLogix
• TÜV SÜD
• VICAM, A Waters Business, SGS SA
• SGS SA
• Fera Science Limited (A Subsidiary Of Capita plc.)
• AB Sciex Pte. Ltd.
• R-Biopharm AG
• TLR International Laboratories
• Deltamune
• Mérieux NutriSciences
• QIMA
• Certified Laboratories
• Romer Labs Division Holding GmbH
• OMIC USA Inc.